$2.15 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 113 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CBST | CUBIST PHARMACEUTICALS INCcall | $95,325,000 | +31.6% | 1,500,000 | 0.0% | 4.43% | +29.9% | |
| VOLCANO CORPORATIONnote 1.750%12/0 | $51,660,000 | +12.0% | 50,000,000 | 0.0% | 2.40% | +10.5% | ||
| AZN | ASTRAZENECA PLCsponsored adr | $48,191,000 | +9.8% | 928,000 | 0.0% | 2.24% | +8.3% | |
| INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1 | $42,155,000 | +3.9% | 41,523,000 | 0.0% | 1.96% | +2.5% | ||
| INTERMUNE INCnote 2.500% 9/1 | $37,234,000 | +9.3% | 41,570,000 | 0.0% | 1.73% | +7.9% | ||
| BROOKDALE SR LIVING INCnote 2.750% 6/1 | $29,258,000 | -0.7% | 25,000,000 | 0.0% | 1.36% | -2.0% | ||
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $28,428,000 | +6.9% | 4,333,475 | 0.0% | 1.32% | +5.4% | |
| AGN | ALLERGAN INCcall | $27,135,000 | +7.4% | 300,000 | 0.0% | 1.26% | +6.0% | |
| PACB | PACIFIC BIOSCIENCES CALIF IN | $26,962,000 | +118.2% | 4,884,368 | 0.0% | 1.25% | +115.5% | |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $26,380,000 | +21.1% | 23,000,000 | 0.0% | 1.23% | +19.6% | ||
| ACCURAY INCnote 3.750% 8/0 | $22,030,000 | +8.4% | 21,200,000 | 0.0% | 1.02% | +7.0% | ||
| BDSI | BIODELIVERY SCIENCES INTL IN | $14,213,000 | +33.7% | 2,617,586 | 0.0% | 0.66% | +31.9% | |
| EW | EDWARDS LIFESCIENCES CORPcall | $13,926,000 | +3.6% | 200,000 | 0.0% | 0.65% | +2.4% | |
| DENDREON CORPnote 4.750% 6/1 | $13,212,000 | -2.9% | 13,740,000 | 0.0% | 0.62% | -4.2% | ||
| DEPO | DEPOMED INC | $11,242,000 | +32.9% | 1,505,000 | 0.0% | 0.52% | +31.1% | |
| INTERMUNE INCnote 2.500%12/1 | $10,510,000 | +31.0% | 7,500,000 | 0.0% | 0.49% | +29.4% | ||
| MEIP | MEI PHARMA INC | $9,250,000 | +57.8% | 822,199 | 0.0% | 0.43% | +55.8% | |
| ACCURAY INCnote 3.500% 2/0 | $7,521,000 | +20.2% | 5,000,000 | 0.0% | 0.35% | +18.6% | ||
| ALERE INCnote 3.000% 5/1 | $6,052,000 | +6.0% | 5,750,000 | 0.0% | 0.28% | +4.5% | ||
| FRX | FOREST LABS INCcall | $4,279,000 | +4.4% | 100,000 | 0.0% | 0.20% | +3.1% | |
| MANNKIND CORPnote 3.750%12/1 | $2,062,000 | +2.0% | 2,090,000 | 0.0% | 0.10% | +1.1% | ||
| PTN | PALATIN TECHNOLOGIES INC | $1,380,000 | +11.3% | 2,000,000 | 0.0% | 0.06% | +10.3% | |
| IRWD | IRONWOOD PHARMACEUTICALS INCput | $1,184,000 | +19.2% | 100,000 | 0.0% | 0.06% | +17.0% | |
| SLTM | SOLTA MED INC | $702,000 | -9.2% | 339,063 | 0.0% | 0.03% | -8.3% | |
| ICAD | ICAD INC | $205,000 | -12.0% | 38,887 | 0.0% | 0.01% | -9.1% | |
| OREX | OREXIGEN THERAPEUTICS INC | $138,000 | +4.5% | 22,575 | 0.0% | 0.01% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 33 | Q2 2024 | 3.3% |
| BIOCRYST PHARMACEUTICALS INC | 32 | Q2 2024 | 2.2% |
| MOLINA HEALTHCARE INC | 27 | Q2 2024 | 1.7% |
| BROOKDALE SR LIVING INC | 26 | Q2 2024 | 2.2% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| DECIPHERA PHARMACEUTICALS IN | 24 | Q1 2024 | 2.0% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-09-17 |
| 3 | 2024-09-12 |
| N-PX | 2024-08-29 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-07-17 |
| 4 | 2024-07-15 |
| 4 | 2024-07-11 |
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.